← Leaderboards
Deeba Husain
Massachusetts Eye And Ear Infirmary
$2,799,440
Attributed
$2,799,440
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $706.3K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,799,440 · 1
By mechanism
R01$2,799,440 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Eye And Ear Infirmary
Same institution · by research overlap
- Elizabeth Jeffries Rossin$553,906
- Nathaniel Bryan David Parsons$180,956
- Margaret M Deangelis$3,722,941
- Demetrios Vavvas$1,948,442
Others in their field
Other Emerging Leaders on “Genomics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- Scott Topper · Broad Institute, Inc.$153,234,573
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,892,657
- Leonard Freedmand · Leidos Biomedical Research, Inc.$96,686,407
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Scott Andrew Sutherland · Vignet, Inc.$37,105,117
Research focus
GenomicsMetabolomeExhibitsGenomeInsightLipidsElderlyEnvironmental ExposureDiagnosisGeneticEarly TreatmentGlycerophospholipidsAge Related Macular DegenerationEarly InterventionCharacteristicsBiologicalBiological MarkersBiomarker IdentificationComplexBlindnessGene InteractionGenesDisease ProgressionMetabolomics
Grant awards (6)
Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration$706,337
R01 · FY2025 · EY · contact PI
Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration$419,891
R01 · FY2024 · EY · contact PI
Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration$420,031
R01 · FY2023 · EY · contact PI
Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration$407,562
R01 · FY2022 · EY · contact PI
Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration$407,690
R01 · FY2021 · EY · contact PI
Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration$437,929
R01 · FY2020 · EY · contact PI